Subthreshold micropulse laser treatment for autosomal recessive bestrophinopathy complicated by macular neovascularization.

IF 1.4 4区 医学 Q3 OPHTHALMOLOGY
Rosa Buonamassa, Francesca Palumbo, Giacomo Boscia, Giacomo Scotti, Andrea Ferrara, Fabio De Vitis, Mariagrazia Pignataro, Alba Chiara Termite, Luca Landini, Giovanni Alessio, Francesco Boscia, Pasquale Viggiano
{"title":"Subthreshold micropulse laser treatment for autosomal recessive bestrophinopathy complicated by macular neovascularization.","authors":"Rosa Buonamassa, Francesca Palumbo, Giacomo Boscia, Giacomo Scotti, Andrea Ferrara, Fabio De Vitis, Mariagrazia Pignataro, Alba Chiara Termite, Luca Landini, Giovanni Alessio, Francesco Boscia, Pasquale Viggiano","doi":"10.1177/11206721241291100","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To present a case of autosomal recessive bestrophinopathy (ARB) complicated by intraretinal fluid and subretinal fluid, successfully managed with navigated subthreshold micropulse laser (SML) treatment.</p><p><strong>Obervations: </strong>A 25-year-old female was referred to our clinic by her ophthalmologist due to a diagnosis of reduced vision in both eyes. The patient presented with a visual acuity of 0.9 logMAR in both eyes. Structural optical coherence tomography (OCT) revealed bilateral intraretinal fluid (IRF) and subretinal fluid (SRF), while OCT angiography (OCT-A) demonstrated bilateral macular neovascularization (MNV). Following the initiation of intravitreal therapy with anti-VEGF agents, administered via monthly injections for one year, we observed no improvement in visual acuity or resolution of IRF and SRF. SML treatment was administered to both eyes in the macular region. At the 3-month follow-up visit, OCT revealed complete resolution of IRF in the right eye and partial resolution of IRF in the left eye, and best-corrected visual acuity (BCVA) improved from 0.9 logMAR to 0.7 logMAR.</p><p><strong>Conclusions and importance: </strong>In our case, SML emerges as a promising treatment modality for patients with ARB complicated by MNV who exhibit poor response to anti-VEGF therapy. However, further prospective studies with longer follow-up periods and larger cohorts are warranted to confirm the optimal treatment strategy in ARB.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11206721241291100","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To present a case of autosomal recessive bestrophinopathy (ARB) complicated by intraretinal fluid and subretinal fluid, successfully managed with navigated subthreshold micropulse laser (SML) treatment.

Obervations: A 25-year-old female was referred to our clinic by her ophthalmologist due to a diagnosis of reduced vision in both eyes. The patient presented with a visual acuity of 0.9 logMAR in both eyes. Structural optical coherence tomography (OCT) revealed bilateral intraretinal fluid (IRF) and subretinal fluid (SRF), while OCT angiography (OCT-A) demonstrated bilateral macular neovascularization (MNV). Following the initiation of intravitreal therapy with anti-VEGF agents, administered via monthly injections for one year, we observed no improvement in visual acuity or resolution of IRF and SRF. SML treatment was administered to both eyes in the macular region. At the 3-month follow-up visit, OCT revealed complete resolution of IRF in the right eye and partial resolution of IRF in the left eye, and best-corrected visual acuity (BCVA) improved from 0.9 logMAR to 0.7 logMAR.

Conclusions and importance: In our case, SML emerges as a promising treatment modality for patients with ARB complicated by MNV who exhibit poor response to anti-VEGF therapy. However, further prospective studies with longer follow-up periods and larger cohorts are warranted to confirm the optimal treatment strategy in ARB.

阈下微脉冲激光治疗伴有黄斑新生血管的常染色体隐性富集蛋白病。
目的:介绍一例常染色体隐性遗传嗜酸性粒细胞增多症(ARB)并发视网膜内积液和视网膜下积液的病例,该病例通过导航阈下微脉冲激光(SML)治疗获得成功:一位 25 岁的女性因双眼视力下降被眼科医生转诊至我院。患者双眼视力均为 0.9 logMAR。结构性光学相干断层扫描(OCT)显示双侧视网膜内积液(IRF)和视网膜下积液(SRF),而 OCT 血管造影(OCT-A)显示双侧黄斑新生血管(MNV)。在开始使用抗血管内皮生长因子药物进行玻璃体内治疗(每月注射一次,为期一年)后,我们观察到视力没有改善,IRF 和 SRF 也没有消退。双眼黄斑区均接受了 SML 治疗。3 个月随访时,OCT 显示右眼 IRF 完全消退,左眼 IRF 部分消退,最佳矫正视力(BCVA)从 0.9 logMAR 提高到 0.7 logMAR:在我们的病例中,对于抗血管内皮生长因子治疗效果不佳的 ARB 并发 MNV 患者来说,SML 是一种很有前景的治疗方式。然而,还需要进一步开展随访时间更长、队列更大的前瞻性研究,以确定 ARB 的最佳治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
372
审稿时长
3-8 weeks
期刊介绍: The European Journal of Ophthalmology was founded in 1991 and is issued in print bi-monthly. It publishes only peer-reviewed original research reporting clinical observations and laboratory investigations with clinical relevance focusing on new diagnostic and surgical techniques, instrument and therapy updates, results of clinical trials and research findings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信